NEWARK, N.Y., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Ultralife Corporation (Nasdaq:ULBI) reported an operating profit from continuing operations of $2.4 million on revenue of $29.3 million for the quarter ended December 31, 2012. For the fourth quarter of 2011, the company reported operating income from continuing operations of $1.8 million on revenue of $29.5 million.
"Ultralife's fourth quarter results demonstrate the earnings power of our business model. Although revenue was flat year-over-year with a sizeable increase in Communications Systems sales neutralized by ongoing weakness in U.S. government spending for Battery & Energy Products, we generated gross margin above 30% for the second consecutive quarter and operating margin of 8%, a 200 basis point improvement. We achieved these margin gains while continuing to invest in sales and new product development. In addition, we continued to drive working capital efficiency, generating free cash flow and ending the year with cash of $10 million," said Michael D. Popielec, Ultralife's president and chief executive officer.
"During 2013 we intend to further invest in new product development and broadening our sales reach ahead of revenue generation, and funding these investments through continued manufacturing productivity gains and reductions in discretionary spending. With a significantly lower cost infrastructure, an expanding set of global project opportunities for our new products and new sales leadership, we are looking forward to the further operating leverage revenue growth will bring," concluded Popielec.
Fourth Quarter 2012 Financial Results
During the quarter, management elected not to renew the lease for its U.K. manufacturing facility which expires on March 24, 2013, and to relocate its sales and services operations to a smaller facility. As a result of this decision, Ultralife is required to restore the facility back to its original condition per a previous contractual commitment. The estimated costs associated with the restoration total approximately $950,000 of which $200,000 has been recorded in fourth quarter general & administrative expenses and $750,000 has been recorded as discontinued operations. In addition, Ultralife expects to realize net savings of approximately $500,000 on an annualized basis beginning in the second quarter of 2013.
Discontinued operations for the fourth quarter of 2011 include the operating results of RedBlack which was sold in the third quarter of 2012 and the final costs associated with exiting the Energy Services business.
All revenue, gross margin and operating expense amounts presented below represent results from continuing operations.
Revenue was $29.3 million, compared to $29.5 million for the fourth quarter of 2011, reflecting an increase of $4.8 million in Communications Systems sales offset by a $5.0 million decrease in Battery & Energy Products sales. Battery & Energy Products sales were $18.8 million, compared to $23.9 million last year, a 21% decline, reflecting for the most part the continued slowdown in the government and defense order rate for rechargeable and non-rechargeable batteries. Communications Systems sales were $10.4 million, compared to $5.6 million for the same period last year, an increase of 85%, reflecting the fulfillment of large orders for amplifiers from international defense customers and continued demand for amplifiers from the U.S. military. New business development during the year has resulted in an increased mix of sales from international customers from 5% to 40% for Communications Systems.
Gross profit was $9.5 million, or 32.3% of revenue, compared to $8.9 million, or 30.0% of revenue, for the same quarter a year ago, an increase of 230 basis points primarily attributable to a higher mix of Communications Systems sales. Battery & Energy Products' gross margin was 27.0%, compared to 29.1% last year, a 210 basis point decrease due to lower sales volumes partially offset by improved 9-volt margins. Communications Systems' gross margin was 41.9%, an increase of 790 basis points over the 34.0% gross margin reported last year, which resulted from higher volumes and favorable sales mix.
Operating expenses were $7.1 million, compared to $7.1 million a year ago, reflecting lower discretionary spending and headcount reductions completed in the first half of 2012 offset by increases in selling and new product development expenses. Included in the 2012 operating expenses is a $200,000 charge related to the non-renewal of the company's U.K. lease described above. As a percent of revenue, operating expenses were 24.3%, compared to 24.0% a year ago.
Although revenue was flat year-over-year for the fourth quarter, operating income increased 32% to $2.4 million from $1.8 million on the strength of gross margin gains. Likewise, operating margin was 8.0%, compared to 6.0% for the year-earlier period, an increase of 200 basis points.
Net income from continuing operations was $2.1 million, or $0.12 per share, compared to net income of $1.3 million, or $0.08 per share, for the fourth quarter of 2011. Net loss from discontinued operations was $0.7 million, or $0.04 per share, compared to a net income of $0.4 million, or $0.02 per share, for the same quarter last year.
Outlook
For 2013, management expects low- to mid-single digit organic revenue growth reflecting strong growth in Communications Systems sales and modest gains in the Battery & Energy Products business, despite continued constraints on U.S. government spending. Based on this outlook for revenue growth, ongoing productivity improvements and plans to continue prudently investing in new product development, management expects to increase operating profitability for the year and to generate a mid-single digit operating margin.
Management cautions that the timing of orders and shipments may cause variability in quarterly results.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from portable power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.
This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: potential reductions in U.S. military spending, uncertain global economic conditions and acceptance of our new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.
Conference Call Information
Ultralife will hold its fourth quarter earnings conference call today at 10:00 AM ET. To participate, please call (800) 915-4836, identify yourself and ask for the Ultralife call. The conference call will also be broadcast live over the Internet at http://investor.ultralifecorp.com. To listen to the call, please go to the web site at least fifteen minutes early to download and install any necessary audio software. For those who cannot listen to the live webcast, a replay of the webcast will be available shortly after the call at the same location.
|
|
|
ULTRALIFE CORPORATION |
|
CONSOLIDATED BALANCE SHEETS |
|
(In Thousands, Except Per Share Amounts) |
|
(unaudited) |
|
|
|
|
|
|
|
|
December 31, |
December 31, |
|
ASSETS |
2012 |
2011 |
|
|
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ 10,078 |
$ 5,486 |
|
Trade accounts receivable, net |
20,913 |
19,903 |
|
Inventories |
30,370 |
34,967 |
|
Prepaid expenses and other current assets |
2,461 |
3,877 |
|
Total current assets |
63,822 |
64,233 |
|
|
|
|
|
Property and equipment |
12,415 |
12,588 |
|
|
|
|
|
Other assets: |
|
|
|
Goodwill, intangible and other assets |
21,481 |
23,994 |
|
|
|
|
|
Total Assets |
$ 97,718 |
$ 100,815 |
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
Short-term debt and current portion of long-term debt |
$ -- |
$ -- |
|
Accounts payable |
11,357 |
13,766 |
|
Other current liabilities |
8,540 |
9,392 |
|
Total current liabilities |
19,897 |
23,158 |
|
|
|
|
|
Long-term liabilities: |
|
|
|
Other long-term liabilities |
4,370 |
4,431 |
|
|
|
|
|
Shareholders' equity: |
|
|
|
Ultralife equity: |
|
|
|
Common stock, par value $0.10 per share |
1,886 |
1,874 |
|
Capital in excess of par value |
173,791 |
172,309 |
|
Accumulated other comprehensive loss |
(620) |
(985) |
|
Accumulated deficit |
(93,883) |
(92,280) |
|
|
81,174 |
80,918 |
|
Less --- Treasury stock, at cost |
7,658 |
7,658 |
|
Total Ultralife equity |
73,516 |
73,260 |
|
Noncontrolling interest |
(65) |
(34) |
|
Total shareholders' equity |
73,451 |
73,226 |
|
|
|
|
|
Total Liabilities and Shareholders' Equity |
$ 97,718 |
$ 100,815 |
|
|
|
|
|
ULTRALIFE CORPORATION |
|
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME |
|
(In Thousands, Except Per Share Amounts) |
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
Three-Month Periods Ended |
Twelve-Month Periods Ended |
|
|
December 31, |
December 31, |
December 31, |
December 31, |
|
|
2012 |
2011 |
2012 |
2011 |
|
|
|
|
|
|
|
Revenues: |
|
|
|
|
|
Battery & energy products |
$ 18,846 |
$ 23,882 |
$ 71,084 |
$ 108,203 |
|
Communications systems |
10,423 |
5,624 |
30,573 |
27,534 |
|
Total revenues |
29,269 |
29,506 |
101,657 |
135,737 |
|
|
|
|
|
|
|
Cost of products sold: |
|
|
|
|
|
Battery & energy products |
13,760 |
16,936 |
53,522 |
83,034 |
|
Communications systems |
6,058 |
3,713 |
19,405 |
18,512 |
|
Total cost of products sold |
19,818 |
20,649 |
72,927 |
101,546 |
|
|
|
|
|
|
|
Gross profit |
9,451 |
8,857 |
28,730 |
34,191 |
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
Research and development |
1,511 |
1,680 |
7,216 |
8,593 |
|
Selling, general, and administrative |
5,587 |
5,401 |
21,628 |
23,186 |
|
Total operating expenses |
7,098 |
7,081 |
28,844 |
31,779 |
|
|
|
|
|
|
|
Operating income (loss) |
2,353 |
1,776 |
(114) |
2,412 |
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
Interest income |
-- |
1 |
4 |
5 |
|
Interest expense |
(124) |
(115) |
(440) |
(559) |
|
Miscellaneous |
(41) |
(168) |
(24) |
171 |
|
Income (loss) from continuing operations before income taxes |
2,188 |
1,494 |
(574) |
2,029 |
|
|
|
|
|
|
|
Income tax provision-current |
152 |
(101) |
539 |
32 |
|
Income tax provision - deferred |
(35) |
297 |
15 |
448 |
|
Total income taxes |
117 |
196 |
554 |
480 |
|
|
|
|
|
|
|
Net income (loss) from continuing operations |
2,071 |
1,298 |
(1,128) |
1,549 |
|
|
|
|
|
|
|
Discontinued operations: |
|
|
|
|
|
Income (loss) from discontinued operations, net of tax |
(680) |
440 |
(501) |
(3,819) |
|
|
|
|
|
|
|
Net income (loss) |
1,391 |
1,738 |
(1,629) |
(2,270) |
|
|
|
|
|
|
|
Net loss attributable to noncontrolling interest |
-- |
19 |
31 |
58 |
|
|
|
|
|
|
|
Net income (loss) attributable to Ultralife |
$ 1,391 |
$ 1,757 |
$ (1,598) |
$ (2,212) |
|
|
|
|
|
|
|
Other comprehensive income (loss): |
|
|
|
|
|
Foreign currency translation adjustments |
446 |
9 |
365 |
277 |
|
|
|
|
|
|
|
Comprehensive income (loss) attributable to Ultralife |
$ 1,837 |
$ 1,766 |
$ (1,233) |
$ (1,935) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Ultralife common shareholders - basic |
|
|
|
|
|
Continuing operations |
$ 0.12 |
$ 0.08 |
$ (0.06) |
$ 0.09 |
|
Discontinued operations |
$ (0.04) |
$ 0.02 |
$ (0.03) |
$ (0.22) |
|
Total |
$ 0.08 |
$ 0.10 |
$ (0.09) |
$ (0.13) |
|
Net income (loss) attributable to Ultralife common shareholders - diluted |
|
|
|
|
|
Continuing operations |
$ 0.12 |
$ 0.08 |
$ (0.06) |
$ 0.09 |
|
Discontinued operations |
$ (0.04) |
$ 0.02 |
$ (0.03) |
$ (0.22) |
|
Total |
$ 0.08 |
$ 0.10 |
$ (0.09) |
$ (0.13) |
|
|
|
|
|
|
|
Weighted average shares outstanding - basic |
17,443 |
17,331 |
17,403 |
17,304 |
|
Weighted average shares outstanding - diluted |
17,443 |
17,347 |
17,403 |
17,336 |
CONTACT: Company Contact:
Ultralife Corporation
Philip Fain
(315) 210-6110
pfain@ulbi.com
Investor Relations Contact:
Lippert/Heilshorn & Associates
Jody Burfening
(212) 838-3777
jburfening@lhai.com
